MedTrace Logo

Ramadan Experience of Individuals With Type 2 Diabetes

NCT07384728 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-02-03

No results posted yet for this study

Summary

This study aims to examine the effects of fasting during Ramadan on treatment adherence, psychological adjustment, and glycemic control in individuals with type 2 diabetes. While Ramadan fasting is a religious practice, it can also pose health risks such as hypoglycemia, hyperglycemia, and metabolic imbalance in individuals with diabetes. Adherence to treatment and self-care, as well as psychosocial adjustment, are crucial in the effective management of diabetes. Given that a large portion of Turkey's population is Muslim, comparing individuals with type 2 diabetes who fast and those who do not during Ramadan will contribute to improving patient care within a cultural and religious context. The findings of this study are expected to guide nurses in developing personalized, culturally sensitive care plans tailored to the needs of individuals before, during, and after Ramadan.

Conditions

Interventions

OTHER

The effect of fasting and not fasting during Ramadan.

The effects of fasting and non-fasting during Ramadan on treatment adherence, psychological adjustment, and glycemic control.

Sponsors & Collaborators

  • Gümüşhane Universıty

    collaborator OTHER

  • Dilan aktepe coşar

    lead OTHER

Principal Investigators

  • Dilan aktepe coşar, PhD · Gümüşhane Universıty

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-03
Primary Completion
2026-02-20
Completion
2026-03-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07384728 on ClinicalTrials.gov